Gilead to help India spur Remdesivir production; promises 45,000 vials
In addition to providing support to its licensees to expand their local manufacturing capacity, Gilead will also donate at least 450,000 vials of Remdesivir to help address the immediate needs of Indian patients
PTI | April 27, 2021 | Updated 09:06 IST
American biopharmaceutical company Gilead has announced steps to expand the availability of remdesivir, a key therapeutic medicine used in the treatment of COVID-19 patients, in India. The recent surge of COVID-19 cases in India is having a devastating impact on communities and has created unprecedented pressure on health systems, Johanna Mercier, chief commercial officer of Gilead Sciences said on Monday.